Invion Ltd. (AU:IVX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Invion Limited has announced the appointment of Mr. Tai Phan as the new Company Secretary, bringing his extensive 20-year experience in legal, corporate governance, and compliance roles across various industries to the role. This change comes as Ms. Claire Newstead-Sinclair steps down from the position, with the company expressing gratitude for her service. Invion specializes in the development of Photosoft™ technology for treating cancers, atherosclerosis, and infectious diseases, and is involved in clinical cancer trials funded by RMW Cho Group Limited.
For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.